Mode
Text Size
Log in / Sign up
N/A N=8

Mechanics Analysis of Patients Having a Sigma Mobile Bearing TKA

Knee Prosthesis · Knee Replacement Arthroplasty

Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcome: Primary: In Vivo Linear Knee Kinematics From Fluoroscopy Evaluation During Deep Knee Bend Activity — -4.1; 1.2 mm

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Sigma Posterior Stabilizing Rotating Platform TKA Beaded Poly (Device)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
The University of Tennessee, Knoxville
Primary completion
Nov 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
In Vivo Linear Knee Kinematics From Fluoroscopy Evaluation During Deep Knee Bend Activity
-4.1; 1.2
PRIMARY
Femoral Axial Rotation With Respect to the Tibia During Deep Knee Bend Activity
6.1
PRIMARY
Range of Motion During Flexion of Deep Knee Bend Activity
103
SECONDARY
In Vivo Knee Force Values From Fluoroscopy Evaluation During Deep Knee Bend Activity
1.57; 1.39
SECONDARY
Condyle Contact Area at Maximum Flexion During Deep Knee Bend Activity
109.16; 104.78
SECONDARY
Condyle Contact Stress at Maximum Flexion During Deep Knee Bend Activity
10.66; 10.05

Summary

Utilize previously developed mathematical model to determine in vivo knee mechanics (kinematics, forces, stresses, areas and sound) for subjects having a Sigma Posterior Stabilizing (PS) mobile bearing (MB) total knee arthroplasty (TKA). There are several hypotheses for this study, although the most prominent is: Subjects having a Sigma RP PS TKA will experience polyethylene bearing rotation at 10 years post-operative, similar to their previous evaluations at six months, two years and five years.

Eligibility Criteria

Inclusion Criteria

  • At least six months post-operative
  • Between 40-85 years of age
  • Have a body weight of less than 250 lbs.
  • Judged clinically successful with a AKS greater than 90
  • Have the DePuy Sigma mobile bearing TKA
  • Good-to-excellent post-operative passive flexion
  • Must be willing to sign the IC and HIPAA forms.

Exclusion Criteria

  • Pregnant females
  • Those not willing to sign the IC and HIPAA forms
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01714492). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search